Published on
July 15, 2026
- 12:00 GMT
Verseon’s Precision Oral Anticoagulants Receive New European Patent
SAN JOSE, CA, UNITED STATES, July 15, 2026 /EINPresswire.com/ -- Verseon is pleased to announce that the European Patent Office (EPO) has granted a new patent covering the company’s Precision Oral Anticoagulant (PROAC) program, extending intellectual …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
